Skip to main content

Table 3 The number (percentage) of randomised patients with usable data at the four time points

From: A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study

Variable

T1 (baseline)

T2 (2–4 weeks)

T3 (6 months)

T4 (15 months)

Date of diagnosis

17 (50%)

23 (67.65%)

18 (52.94%)

7 (77.78%)

Diagnosis

32 (94.12%)

25 (73.53%)

21 (61.76%)

7 (77.78%)

Life expectancy from now

15 (44.12%)

8 (23.53%)

9 (26.47%)

1 (11.11%)

Date of last clinic visit

26 (76.47%)

23 (67.65%)

21 (61.76%)

6 (66.67%)

Current medication

32 (94.12%)

25 (73.53%)

21 (61.76%)

7 (77.78%)

Change in symptoms

31 (91.18%)

23 (67.65%)

16 (47.06%)

6 (66.67%)

What NYHA functional class is the patient now in

32 (94.12%)

24 (70.59%)

20 (58.82%)

7 (77.78%)

Number who changed to functional class since last visit

29 (85.29%)

23 (67.65%)

19 (55.88%)

6 (66.67%)

Patient’s medication has changed since last visit?

29 (85.29%)

25 (73.53%)

20 (58.82%)

7 (77.78%)

Change given (of those who changed medication)

4 (100%)

8 (88.89%)

9 (100%)

 

Reasons given (of those who changed medication)

3 (75%)

8 (88.89%)

8 (88.89%)

 

Opinion of whether patient is better, the same or worse

21 (61.76%)

19 (55.88%)

16 (47.06%)

4 (44.44%)

6-min walk

19 (55.8%)

12 (35.3%)

14 (41.1%)

4

Echocardiogram

19 (55.8%)

15 (44.1%)

13 (38.2%)

3

ECG

16 (47.1%)

14 (41.1%)

15 (44.1%)

4

SF-36 score

 SF-36 PCS

91.2% (31/34)

67.6% (23/34)

52.9% (18/34)

77.8% (7/9)

 SF-36 MCS

91.2% (31/34)

67.6% (23/34)

55.9% (19/34)

77.8% (7/9)

 SF-6D

88.2% (30/34)

67.6% (23/34)

52.9% (18/34)

66.7% (6/9)

 BAI

85.3% (29/34)

67.6% (23/34)

61.9% (21/34)

77.8% (7/9)

 BDI

91.2% (31/34)

67.6% (23/34)

58.8% (20/34)

77.8% (7/9)